1. J&J falls short in a Remicade patent case as star drug slips in Q4  FiercePharma
  2. Johnson & Johnson loses Remicade patent on appeal  Minnesota Lawyer
  3. J&J Posts Loss on Tax Charge; Patent Ruling Stings — WSJ  Fox Business
  4. Full coverage